Dudediligence.

Celldex Therapeutics, Inc

CLDXNASDAQ · In Vitro & in Vivo Diagnostic Substances
Write an idea

Filings

Newest first

The annual , the quarterly and the filed between them when something material happens.

  1. Sep 228-KOther events8.019.01
  2. Aug 1413GPassive stake of 5% or more (13G), filed by Price T Rowe Associates Inc /md/
  3. Aug 610-QQuarterly report
  4. Aug 68-KResults of operations2.029.01
  5. Jul 158-KOfficer or director change5.029.01
  6. Jun 268-KOfficer or director change and shareholder vote5.025.079.01
  7. May 710-QQuarterly report
  8. May 78-KResults of operations2.029.01
  9. Apr 2424B5Prospectus for an offering
  10. Apr 28-KMaterial agreement and other events1.018.019.01
  11. Apr 1424B5Prospectus for an offering
  12. Feb 2510-KAnnual report
  13. Feb 258-KResults of operations2.029.01
  14. Nov 10, 202510-QQuarterly report
  15. Nov 10, 20258-KResults of operations2.029.01
  16. Aug 19, 20258-KOther events8.019.01
  17. Aug 7, 202510-QQuarterly report
  18. Aug 7, 20258-KResults of operations2.029.01
  19. Jun 6, 20258-KOfficer or director change and shareholder vote5.025.079.01
  20. May 8, 202510-QQuarterly report
  21. May 8, 20258-KResults of operations2.029.01
  22. Feb 27, 202510-KAnnual report
  23. Feb 27, 20258-KResults of operations2.029.01
  24. Nov 6, 202410-QQuarterly report
  25. Nov 6, 20248-KResults of operations2.029.01